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Loss of Cone Molecular Markers in Rhodopsin-Mutant Human Retinas with
Retinitis Pigmentosa
Abstract
Purpose: To examine the effect of rhodopsin mutations on cone photoreceptors in human retinas with
retinitis pigmentosa (RP).
Methods: Four RP retinas with rhodopsin mutations and four normal retinas were examined by
immunofluorescence with a battery of cell-specific antibodies against cone and rod cytoplasmic and
outer segment membrane proteins. Areas of the retinas were studied that showed maximal preservation
of photoreceptor structure.
Results: All four RP retinas showed loss of rods, ranging from mild (T-17-M), to more severe (P-23-H), to
advanced degeneration (Q-64-ter and G-106-R). The majority of cones in the T-17-M and P-23-H retinas
were cytologically normal but showed loss of immunoreactivity for the cytoplasmic proteins 7G6,
calbindin, and X-arrestin. The cone outer segments (OS) remained positive for cone opsins and
peripherin-2 (rds/peripherin). All remaining cones in the Q-64-ter and G-106-R retinas were degenerate,
with short to absent OS, but had strong reactivity for these cytoplasmic and OS membrane markers.
Cones in the maculas of the RP retinas were degenerate, with short to absent OS, but retained strong
labeling for the cytoplasmic and OS proteins.
Conclusions: Even before cones show cytologic changes in response to rod cell degeneration, they lose
immunoreactivity for certain cytoplasmic proteins. These cones later show shortening and loss of OS,
although their OS membrane proteins remain well labeled. Cones may down regulate expression of both
cytoplasmic and outer segment membrane proteins in response to mutant rod cell dysfunction and/or
cell death in human RP retinas. Such cytologic and immunocytochemical changes in the cones may
presage death of these critical cells in the later stages of RP.
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Loss of cone molecular markers in rhodopsin-mutant human
retinas with retinitis pigmentosa
Sinoj K. John,1Julie E. Smith,1Gustavo D. Aguirre,1,2Ann H. Milam1
1

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA; 2James A. Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY
Purpose: To examine the effect of rhodopsin mutations on cone photoreceptors in human retinas with retinitis pigmentosa
(RP).
Methods: Four RP retinas with rhodopsin mutations and four normal retinas were examined by immunofluorescence with
a battery of cell-specific antibodies against cone and rod cytoplasmic and outer segment membrane proteins. Areas of the
retinas were studied that showed maximal preservation of photoreceptor structure.
Results: All four RP retinas showed loss of rods, ranging from mild (T-17-M), to more severe (P-23-H), to advanced
degeneration (Q-64-ter and G-106-R). The majority of cones in the T-17-M and P-23-H retinas were cytologically normal
but showed loss of immunoreactivity for the cytoplasmic proteins 7G6, calbindin, and X-arrestin. The cone outer segments (OS) remained positive for cone opsins and peripherin-2 (rds/peripherin). All remaining cones in the Q-64-ter and
G-106-R retinas were degenerate, with short to absent OS, but had strong reactivity for these cytoplasmic and OS membrane markers. Cones in the maculas of the RP retinas were degenerate, with short to absent OS, but retained strong
labeling for the cytoplasmic and OS proteins.
Conclusions: Even before cones show cytologic changes in response to rod cell degeneration, they lose immunoreactivity
for certain cytoplasmic proteins. These cones later show shortening and loss of OS, although their OS membrane proteins
remain well labeled. Cones may down regulate expression of both cytoplasmic and outer segment membrane proteins in
response to mutant rod cell dysfunction and/or cell death in human RP retinas. Such cytologic and immunocytochemical
changes in the cones may presage death of these critical cells in the later stages of RP.

cific mutations is essential for understanding the pathophysiology of RP and developing rational therapies for this disease.
To gain insight into the process of rod and cone cell degeneration in RP, we have used immunocytochemistry to evaluate
the retinas of four RP patients with ad RP caused by different
RHO mutations. We report the labeling patterns produced by
a battery of antibodies against cone and rod specific proteins,
and present new evidence on the sequence of molecular
changes occurring in cones that appear structurally normal or
show degenerative changes in RP retinas.

Retinitis pigmentosa (RP) is a group of inherited diseases
that causes primary degeneration of rod photoreceptors in the
human retina [1]. The disease is heterogeneous and caused by
mutations in at least 30 different genes (RetNet). The first RP
gene identified was rhodopsin (RHO) [2-6]. More than 80 different RHO mutations are now believed to cause autosomal
dominant (ad) RP [7-9]. The first symptoms of RP, often noted
in adolescence, are night vision disturbances due to rod dysfunction and cell death. Later in the disease, the critical cone
photoreceptors lose function and degenerate, significantly
decreasing the quality of life for the RP patient.
Many gaps remain in our understanding of how RHO mutations lead to primary rod cell death and secondary cone cell
pathology [10,11]. It is unknown why defective and/or dying
rod cells cause eventual loss of cones. This occurs in patients
with RHO mutations as well as in patients with mutations in
other rod-specific genes (e.g., the cGMP-phosphodiesterase
α- and β-subunits [PDE6A, PDE6B] and the cyclic GMP gated
channel protein α subunit [CNGA1]) [12]. It has been hypothesized that dying rods release substances toxic to the adjacent
cones [13], or that cones are dependent on trophic factor(s)
normally derived from the rods [14-18]. Increased information on molecular changes in cones in retinas with rod-spe-

METHODS
Tissue Preparation: Post mortem adult human eyes were obtained through the donor programs of the Foundation Fighting Blindness (FFB, Hunt Valley, MD) and the University of
Washington Lions Eye Bank (Seattle, WA). The research followed the tenets of the Declaration of Helsinki and informed
consent was obtained from all donors ante mortem. The research was approved by the institutional human subjects review board of the University of Pennsylvania. Four RP and
four normal retinas were evaluated (Table 1). All globes were
fixed for several weeks to months in 4% paraformaldehyde,
with or without 0.5% glutaraldehyde, in 0.1 M phosphate
buffer, pH 7.3, and stored thereafter in 2% paraformaldehyde
in the same buffer. The RP retinas had the following rhodopsin mutations: threonine-17-methionine (T-17-M; FFB-316
[19]), glutamine-64-ter (Q-64-ter; FFB-424 [20]), proline-23-

Correspondence to: Ann H. Milam, Ph.D., Scheie Eye Institute, 51
North 39th Street, Philadelphia, PA, 19104; Phone: (215) 662-8102;
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histidine (P-23-H; FFB-360), and glycine-106-arginine (G106-R; FFB-517 [10]). Clinical information on three of the
patients has been published [10,19,20]. The fourth patient (P23-H mutation; FFB-360) was from a family with ad RP affecting 10 family members in six generations. He had been
night blind since early childhood, lost peripheral vision in his
30’s, and macular vision in his 50’s.
Immunocytochemistry: Retinal samples were sectioned
with a cryostat at 12 µm and processed for immunofluorescence by published techniques [21]. The secondary antibodies (goat anti-rabbit or anti-mouse IgG) were labeled with
Alexa Fluor (green; Molecular Probes, Eugene, OR), Cy-2
(green) or Cy-3 (red; Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA). Nuclei were stained (blue) with DAPI
(1 µg/ml; Molecular Probes). Control sections were treated in
the same way with omission of primary antibody.
Cell specific antibodies prepared in rabbits or mice were
used for immunofluorescence study of the RP and normal
human retinas (Table 2). The immunolabeled retinal sections
were examined with a Leica DMR microscope (Deerfield, IL)

TABLE 1. CHARACTERISTICS OF HUMAN RETINAS USED IN STUDY
Case
-------FFB-316

Age/Gender
---------68 M

PMI (h)
------8.25

FFB-424

50 F

6.5

FFB-360

84 M

FFB-517

99 F

FFB-525

Fixative
-------P

Diagnosis
--------ad RP*

P + G

ad RP**

P + G

ad RP#

5.25

P + G

ad RP##

65 M

6.0

P + G

Normal

0164-00

75 M

4.25

P + G

Normal

0403-93

51 F

3.0

P

Normal

99-11-23

53 M

0.

P

Normal

24.

PMI = post mortem interval
P = 4% paraformaldehyde
G = 0.5% glutaraldehyde
*rhodopsin thr-17-met mutation
**rhodopsin glu-64-ter mutation
#rhodopsin pro-23-his mutation
##rhodopsin gly-106-arg mutation

Normal and RP eyes were fixed and processed by similar methods.

TABLE 2. CELL-SPECIFIC MARKERS USED IN STUDY
Cell
-------------------

Marker
---------

Specificity
------------------

Species
-------

Dilution
--------

Source
----------------

Cones

7G6

unknown

mouse

1:250

P. MacLeish

Cones

-

X-arrestin

mouse

1:100

G. Inana

Cones

JH492

red/green
cone

rabbit
opsin

1:5,000

J. Nathans

Cones

UW-16

red/green
cone opsin

rabbit

1:200

J. Saari

Cones

JH455

blue cone opsin

rabbit

1:5,000

J. Nathans

Cones

PNArhodamine
(RL1072)

cone sheaths

plant
lectin

1:100

Vector Labs

Interphotoreceptor
matrix

-

interphotoreceptor
retinoid-binding
protein

rabbit

1:100

J. Saari

Cones and rods

Per
3Bg/5H2

peripherin-2

mouse

1:30

R. Molday

Cones, rods
bipolar cells

P26

recoverin

rabbit

1:1000

A. Dizhoor

Cones,
Horizontal, bipolar
and amacrine cells

C8666

calbindin

mouse

1:200

Sigma

Cones, rods,
inner retinal cells

A6403

cytochrome C
oxidase

mouse

1:1000

Molecular Probes

Rods

4D2

rhodopsin

mouse

1:40

R. Molday

Rods

-

rhodopsin

rabbit

1:3000

E. Kean

Rods
(S-antigen)

A9C6

rod arrestin

mouse

1:1000

L. Donoso

Astrocytes and
reactive
Müller cells

ZO334

GFAP

rabbit

1:750

Dako

Cell specific antibodies were used to assess cone immunoreactivity in retinas with RHO mutations.
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using epifluorescence and Nomarski differential interference
contrast (DIC) microscopy. The sections were photographed
with Kodak (Rochester, NY) Elite Chrome film, ASA 400.
After each immunofluorescence exposure, the same region was
photographed by Nomarski DIC microscopy. Images were
digitized with a flat bed scanner (Saphir HiRes, Heidelberg
CPS GmbH, Bad Homburg, Germany) using LinoColor Elite
5.1 software (Heidelberg CPS GmbH), imported into a graphics program (PhotoShop 5.0, Adobe, San Jose, CA) and dyesublimation prints were generated.

RESULTS
Normal Retinas: In the normal human retinas, all photoreceptors in the macula and periphery showed the expected patterns of labeling with the cell-specific markers used in this
study. All cones had cytoplasmic and outer segment (OS) labeling with 7G6 (Figure 1A), and X-arrestin (Figure 1B), and
the cytoplasm of their inner segments, cell bodies and synapses was positive with anti-calbindin (Figure 1C), which also
labeled horizontal cells and some bipolar and amacrine cells.
The cytoplasm and OS of all cones and rods were positive
with anti-recoverin, which also labeled a population of cone
Figure 1. Immunocytochemical labeling of normal human
retinas. A. Antibody 7G6 produces labeling of the outer
segments and cytoplasm of
the inner segments, cell bodies and synapses of all cone
photoreceptors. B. Anti-Xarrestin labels the outer segments and the cytoplasm of
the cell bodies and synapses
of all cones. C. Anti-calbindin
labels the cytoplasm of the
cone inner segments, cell bodies and synapses. The horizontal cells and some bipolar
and amacrine cells are also
labeled. D. The outer segments and cytoplasm of the
cones and rods are positive
with anti-recoverin. A population of cone bipolar cells is
also recoverin-positive. E. All
cones are positive with antibody 7G6 (red) and the majority of cone outer segments
are positive (gold) for red/
green cone opsin. F. All cones
are 7G6-positive (red) and a
few cone outer segments
(gold) are blue cone opsinpositive. G. The cone and rod
outer segments are positive
with anti-peripherin-2. H. The
rod outer segments are
rhodopsin-positive but the
cones (*) appear as negative
images.
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bipolar cells (Figure 1D). Most cone OS were labeled with
anti-red/green cone opsin (Figure 1E) and the remaining cone
OS were positive for blue cone opsin (Figure 1F). The cone
and rod OS were labeled with anti-peripherin-2 (rds/peripherin,
Figure 1G) and the rod OS were reactive for rhodopsin (Figure 1H). The cone sheaths were uniform in structure and labeled with PNA-rhodamine (Figure 1I) and the
interphotoreceptor matrix (IPM) was positive for IRBP (Figure 1J). The rod OS were strongly labeled and a few rod cell
bodies and synapses were weakly labeled with anti-rod arrestin
(Figure 1K). Mitochondria in the ellipsoids of cones and rods
were strongly positive for cytochrome C oxidase (Figure 1L).

Mitochondria in the outer and inner plexiform layers, and in
some inner nuclear layer cells, were also labeled with anticytochrome C oxidase (Figure 1L). Immunolabeling with antiGFAP was restricted to astrocytes and Müller end feet (Figure
1M). Treatment of the sections with no primary antibody produced no specific labeling but the retinal pigment epithelium
(RPE) was filled with autofluorescence lipofuscin granules
(Figure 1N).
Threonine-17-Methionine RHO Mutation (FFB-316): As
reported previously [19], the inferior half of this retina was
severely degenerate and contained no photoreceptors. Samples
for the current study were taken from the superior and nasal
Figure 1, continued. I. The extracellular cone sheaths are
uniform in structure and
PNA-positive (red). J. The
inter-photoreceptor matrix is
positive for IRBP (green). All
cones are labeled (red) with
7G6. K. The rod outer segments are strongly labeled
(red) with anti-rod arrestin.
Some rod cell bodies and synapses are weakly positive. L.
Mitochondria in the cone and
rod inner segments (*) are
positive for cytochrome C
oxidase. The inner and outer
plexiform layers and some
cells in the inner nuclear layer
(n) are also labeled. M. Labeling with anti-GFAP
(green) is restricted to astrocytes and Müller end feet. The
cones are labeled (red) with
7G6. N. Control section
treated with no primary antibody shows only auto-fluorescent lipofuscin granules in
the RPE. Autofluorescent lipofuscin is present in the retinal pigment epithelium at the
bottom of the panels. The
scale bar represents 50 µm.
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mid and far periphery, which contained both cones and rods,
and the macula, which contained only scattered cones that
lacked OS. When observed by DIC, cones and rods in the superior regions appeared near normal in numbers and cytology
except for some OS shortening, particularly in the rods. The
superior retina retained 40-50% of outer nuclear layer (ONL)
nuclei in the mid periphery and 50-75% of ONL nuclei in the
far periphery.
Approximately 75% of the cones in the superior retina
had marked loss of 7G6 immunoreactivity in their inner segments, cell bodies and synapses (Figure 2A) even though these
cones were cytologically intact by DIC microscopy (Figure

2B). Cones that had lost 7G6 immunoreactivity could not be
distinguished from neighboring 7G6-positive cones by DIC
(Figure 2B). All cone OS were labeled with anti-peripherin-2,
and most were positive for red/green cone opsin (Figure 2C);
only a few cone OS were labeled with anti-blue cone opsin.
The pattern of labeling with anti-X-arrestin, antirecoverin, and anti-calbindin was very similar to that with 7G6.
Many cones had lost OS and cytoplasmic labeling for Xarrestin (Figure 2D) and double labeling with anti-X-arrestin
and 7G6 showed that the same cones had lost immunoreactivity for both proteins (Figure 2D-F). Immunoreactivity for
calbindin was also absent in the majority of the cones, although
Figure 2. Immunocytochemistry of retina with T17-M RHO mutation. A.
7G6 labels some cone outer
and inner segments, cell
bodies and synapses. The
remainder of the cones have
lost 7G6 immunoreactivity
in their inner segments, cell
bodies and synapses. B.
DIC microscopy of the
same field shown in A, illustrating the near normal
cytologic appearance of the
cones (arrowheads). C.
Only a few cones are labeled with 7G6 (red) but
most cone outer segments
are labeled with anti-red/
green cone opsin (green).
The cone (*) with a 7G6positive but red/green cone
opsin-negative outer segment is presumably a blue
cone. D. Labeling with antiX-arrestin (red) shows that
many cones have lost reactivity for this protein. E.
Double labeling of the field
in D with 7G6 (green) illustrates that the same cones
have lost immunoreactivity
for both arrestin and 7G6. F.
Nomarski image of field
shown in D and E. The
cones are indicated by arrowheads.
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the horizontal, bipolar and amacrine cells in the same sections
continued to show strong labeling with anti-calbindin (Figure
2G). The extracellular domains of cones and rods in the IPM
were examined with PNA lectin and anti-IRBP. The cone
matrix sheaths were shortened and weakly PNA-positive. IRBP
in the IPM was very weakly labeled (Figure 2H). In the macula,
the cone matrix sheaths were strongly PNA-positive but very
short (Figure 2I) and IRBP labeling was absent.
The rod OS were shortened but showed normal intensity
of rhodopsin labeling in the superior retina, as observed in the
controls. Rhodopsin labeling was also delocalized to a few
rod cell bodies and synapses (Figure 2J) but no rod neurite

sprouting was observed. Double labeling with 7G6 and antirhodopsin revealed that rods were well labeled with antirhodopsin in the areas where 7G6 cone labeling was markedly reduced. Rod arrestin was strongly labeled in the rod OS,
inner segments, cell bodies and synapses (Figure 2K). This
labeling pattern was different from the control retinas, where
labeling with anti-arrestin was heaviest in the OS (Figure 1K).
Mitochondria in the rod and cone inner segments were well
labeled with anti-cytochrome C oxidase (Figure 2L). Treatment with anti-GFAP produced a few labeled Müller cell processes extending from the inner retina to the external limiting
membrane, although no correlation could be found between
Figure 2, continued. G. Labeling
with anti-calbindin illustrates
loss of reactivity for this protein
in most cones, although the horizontal, bipolar and amacrine cells
continue to show strong labeling
with the antibody. H.
Immunolabeling with anti-IRBP
reveals very weak reactivity for
this protein (green) in the
interphotoreceptor matrix. The
cones are labeled (red) with 7G6.
I. In the macula, the cone matrix
sheaths (red, *) are very short but
strongly PNA-positive. c, monolayer of cone nuclei; n, inner
nuclear layer. J. In the periphery,
the rod outer segments are shortened but show normal intensity
of labeling with anti-rhodopsin.
One rod (arrowhead) shows cell
body labeling with anti-rhodopsin. K. Rod arrestin is localized
in the rod outer and inner segments, cell bodies and synapses.
L. The rod and cone inner segments (*) are well labeled for the
mitochondrial protein, cytochrome C oxidase. M. GFAP labeling is increased in Müller processes in an area where some
cones have lost 7G6 reactivity
and have ectopic nuclei (arrowheads) in their inner segments. N.
DIC of field in M illustrating the
cytologic features of the cones
(arrowheads). Autofluorescent lipofuscin is present in the retinal
pigment epithelium at the bottom
of the panels. The scale bar represents 50 µm.
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GFAP-positive Müller processes and abnormalities in the rods
or RPE. GFAP-labeling was increased in Müller processes in
areas where cones had lost 7G6 reactivity and had nuclei displaced into their inner segments (Figure 2M). DIC microscopy revealed that near normal numbers of cones were retained in these regions (Figure 2N).
Glutamine-64-ter RHO Mutation (FFB-424): Retinal
samples were taken from the temporal far periphery and the
macula. This retina showed advanced disease and the ONL
was reduced to 1-3 layers of cells in the peripheral region examined. All photoreceptors had absent or very short outer segments. All remaining cones, as identified by DIC, were strongly

labeled with 7G6 (Figure 3A), anti-X-arrestin, anti-recoverin
and anti-calbindin. The shortened cone OS were positive for
peripherin-2 and red/green cone opsin (Figure 3B) but not for
blue cone opsin. The cone matrix sheaths were very short and
PNA-positive but IRBP-labeling was absent. The macular
cones were reduced to a single layer of cell bodies that showed
uniformly strong labeling with 7G6 (Figure 3C) and anti-Xarrestin. The cone OS were tiny but well labeled with 7G6
(Figure 3C), anti-peripherin-2 and anti-red/green cone opsin.
Their matrix sheaths were shortened but strongly PNA-positive (Figure 3D). Scattered rhodopsin-positive rod cell bodies
were retained in the macula (not shown).
Figure 3. Immunocytochemistry of retina with Q-64-ter
RHO mutation. A. All remaining cones are strongly
labeled with 7G6. Their
outer segments are very
short. B. The shortened cone
outer segments (gold) are
positive for red/green cone
opsin and 7G6 (red). C. The
macular cones are reduced to
a single layer of cell bodies
that are strongly labeled with
7G6. Their outer segments
have formed a layer of 7G6positive debris in the
subretinal space. D. The matrix sheaths of the macular
cones are shortened but
strongly PNA-positive (red).
c, cone nuclei; n, inner
nuclear layer. E. As revealed
by labeling with antirhodopsin, the rods have
very short or absent outer
segments and rhodopsin is
delocalized to their cell bodies and long neurites extending into the inner retina. Arrowhead indicates inner limiting membrane. F. GFAPpositive Müller processes
(green) are hypertrophied.
Rhodopsin in the rod cell
bodies (r) and neurites is labeled red. Autofluorescent
lipofuscin is present in the
retinal pigment epithelium at
the bottom of the panels. The
scale bar represents 50 µm.
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Rods in the peripheral retina had very short OS strongly
reactive for rhodopsin, which was also present in the surface
membranes of the inner segments and cell bodies. Many rods
had rhodopsin-positive neurites extending into the inner retina
as far as the inner limiting membrane (Figure 3E). Labeling
with anti-peripherin-2 was restricted to the shortened rod OS.
Arrestin and recoverin were well labeled in the rod inner segments and cell bodies. Mitochondria in the rod and cone inner
segments were very weakly reactive for cytochrome C oxidase. Müller cell processes were hypertrophied and strongly
positive for GFAP (Figure 3F).

Proline-23-Histidine RHO Mutation (FFB-360): Retinal
samples were taken from the nasal and temporal mid and far
periphery. Macular samples were not available. The peripheral regions showed retention of 1-4 rows of ONL nuclei.
Examination of the peripheral regions by DIC revealed shortening and loss of rod and cone OS. Approximately 30% of the
remaining cones had reduced immunoreactivity for 7G6, Xarrestin and calbindin. The rest of the cones showed normal
labeling with antibodies to these proteins. Most cones were
well labeled with 7G6 (Figure 4A,B). The shortened cone OS
were reactive for peripherin-2 and red/green (Figure 4C) but
Figure 4. Immunocytochemistry of retina with P-23-H RHO
mutation. A. Most remaining
cones are well labeled with
7G6. B. DIC microscopy of
same field as Figure 4A. The
cones are indicated by the arrowheads. C. Some cones are
well labeled with 7G6 (red)
and most cone outer segments
are positive (gold) for red/
green cone opsin. D. IRBP
immunolabeling (green) is absent from the interphotoreceptor matrix. The cones are 7G6positive (red). The retinal pigment epithelium cells are enlarged and engorged with
autofluorescent (red) lipofuscin granules. E. Cytochrome C
oxidase labeling is weak in the
shortened photoreceptor inner
segments (*). F. GFAP labeling is strong in the hypertrophied Müller cell processes.
Some cones, whose outer segments are tiny, are 7G6-positive (red). Autofluorescent lipofuscin is present in the retinal pigment epithelium at the
bottom of the panels. The scale
bar represents 50 µm.
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not blue cone opsin. The cone matrix sheaths were very short
and PNA-positive but IRBP labeling was absent (Figure 4D).
The rods were markedly reduced in number in all retinal
regions. The rod OS were shortened and rhodopsin was delocalized to the inner segments, cell bodies and synapses. Rod
arrestin was localized to the rod OS, inner segments and cell
bodies. Mitochondria in the rod and cone inner segments were
weakly labeled with anti-cytochrome C oxidase (Figure 4E).
GFAP was increased in the hypertrophied Müller cell processes
(Figure 4F).
Glycine-106-Arginine RHO Mutation (FFB-517): Retinal samples were taken from the nasal and temporal far pe-

riphery and the macula. Like FFB-424 (Q-64-ter), this retina
had advanced disease, and only 1-3 layers of cones and rods
with very short outer segments were present in the peripheral
regions examined. All remaining cones, identified by DIC
microscopy, were well labeled with 7G6 (Figure 5A,B) antiX-arrestin, anti-calbindin, and anti-recoverin. The short cone
OS were positive for peripherin-2, and red/green (Figure 5C,D)
but not blue cone opsin. The cone matrix sheaths were very
short and weakly PNA-positive but IRBP labeling was absent. The macula of this retina showed geographic atrophy
and choroidal neovascularization, and was not used in the
present study.
Figure 5. Immunocytochemistry of retina with G-106-R
RHO mutation. A. All remaining cones are strongly
positive with 7G6. Their
outer segments are short to
absent. B. The cones (arrowheads) are documented by
DIC microscopy in the same
field shown in Figure 5A. C.
The shortened cone outer
segments are positive for red/
green cone opsin (gold). The
cone cytoplasm is 7G6-positive (red). D. Nomarski image of field in Figure 5C illustrates the cones (arrowheads). E. As revealed by
anti-rhodopsin labeling, the
rods have tiny or absent outer
segments and rhodopsin (red)
is localized to the cell bodies
(r) and neurites. F. Hypertrophied Müller processes are
strongly positive for GFAP
(green), and the few remaining cones (arrowheads) are
well labeled with 7G6 (red).
Autofluorescent lipofuscin is
present in the retinal pigment
epithelium at the bottom of
the panels. The scale bar represents 50 µm.
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Rods in this retina had tiny or absent OS and rhodopsin
was delocalized to their cell bodies and extensive neurites that
projected into the inner retina (Figure 5E). The few remaining
rod OS were peripherin-2-positive. Most rod inner segments
and cell bodies were weakly labeled with anti-arrestin. All
remaining rods were strongly recoverin-positive. The rod and
cone inner segments were shortened and were not reactive for
cytochrome C oxidase. Hypertrophied Müller cell processes
were strongly reactive for GFAP (Figure 5F).

are losing up to 75% of their OS. Consistent with relatively
normal morphology of these cones, cone dysfunction is not
detectable until there is greater than 75% loss of rod OS [10].
In advanced disease with severe loss of rods, as seen in
the Q-64-ter and G-106-R retinas, the few remaining cones
showed strong reactivity for all cytoplasmic proteins examined. It is possible that the cones lacking cytoplasmic proteins
had died but that these cones survived because they still expressed these proteins, although this argument is somewhat
circular. Little is known about the control of expression of
photoreceptor proteins, but this observation offers a clue that
not all cones depend on adjacent rods for their survival. In the
RP retinas, the maculas usually show loss of nearly all rods
and many of the cones, with reduction of the remaining cones
to a monolayer of cells with wide cell bodies and tiny or absent outer segments [1]. These cones can provide reasonably
good visual acuity [29] and closely resemble those in the maculas of newborn human infants [30], again suggesting that the
RP disease progress results in regressed differentiation of the
cones.
Several lines of evidence indicate that death of mutant
photoreceptor cells can be delayed by treatment with various
growth/survival factors [15,31], some of which are intrinsic
to human retina [32]. However, the mechanism(s) of rescue
are not known and there is evidence that some neurotrophic
factors activate signaling pathways in Müller cells and other
cells of the inner retina, but not in photoreceptors themselves
[33,34]. The relationship between Müller cells and cones in
degenerate retinas is not well understood, although a recent
study demonstrated that hyperplastic Müller processes are preferentially associated with cones in experimentally detached
cat retinas [35]. Interestingly, in the present study Müller cell
processes had accumulated GFAP in areas where cone cells
showed loss of cytoplasmic protein reactivity and ectopic nuclei, although cytologically these cones were otherwise unremarkable.
Cytochrome C oxidase was decreased in the inner segments of cones in the severely degenerate retinas with the Q64-ter and G-106-R RHOmutations. A similar reduction in cytochrome C oxidase was noted in the inner segments of photoreceptors in detached cat retinas [36]. Maintaining the cats
in hyperoxia prevented the loss of cytochrome C oxidase immunoreactivity in the photoreceptors [36]. It is not known if
similar loss of cytochrome C oxidase occurs in animal models
of RP, as observed here in the human RP retinas, or if supplemental oxygen would prevent or reverse this pathologic
change.
We found that the mutant rods showed a different pattern
of immunolabeling with anti-arrestin than the controls. As
noted previously in light adapted bovine retinas [37], in the
normal human retinas the labeling with anti-arrestin was most
intense in the OS, with weaker labeling in the cell bodies and
synapses. In the RP retinas examined here (Figure 2K, for example), labeling with anti-arrestin was strong in the rod cell
bodies and synapses as well as the OS, more closely resembling the pattern found in dark adapted rods. These observa-

DISCUSSION
During development of the primate retina, the structural proteins of cone outer segments, the cone opsins and peripherin2, are expressed before the cytoplasmic proteins [22-24]. Specifically, blue cone opsin is expressed before red/green cone
opsin, and the cone visual transduction proteins (alphatransducin, phosphodiesterase and rhodopsin kinase) are expressed even later [22]. Although the function of 7G6 is not
known, this cytoplasmic protein is also expressed after the
opsins in some human cones [25; Personal communication, P.
K. Swain]. In the RP retinas evaluated in this study, it appears
that cones have reversed the sequence of normal development
and regressed to a more primitive state, retaining OS structural proteins but lacking their specialized cytoplasmic proteins. As these cone cells are stressed and possibly dysfunctional in response to loss or dysfunction of neighboring rods,
they may down regulate expression of the proteins that characterize their differentiated state and retain only their structural proteins. It is also possible that cones degrade cytoplasmic proteins as an early step in apoptosis. Little is known about
the rate of turnover of normal cone OS structural proteins, the
opsins and peripherin-2 [26,27]. This process may be very
slow and require relatively little energy expenditure by the
dedifferentiated cones to maintain their diminutive OS. Protein turnover experiments in cones of animal models for human RP would help to elucidate this process.
The loss of cone immunoreactivity is most clearly illustrated in the T-17-M RHO retina. The cone OS, although
slightly shortened, showed qualitatively normal labeling with
anti-peripherin-2 and anti-red/green cone opsin. However, reactivity for several cytoplasmic proteins was decreased in many
of the otherwise normal appearing cones surrounded by T-17M mutant rods. It should be noted that although these cones
appeared normal at the level of DIC microscopy, further studies to assess the cone cytology are needed using electron microscopy.
In a given area, the same cones showed loss of labeling
with 7G6, anti-X-arrestin, anti-calbindin, and anti-recoverin.
Very similar observations were made on cones surrounded by
mutant rods with shortened OS in rhodopsin-transgenic pigs
[28]. The present results may also correlate with the physiologic demonstration of cone dysfunction spatially following
the expanding “front” of rod dysfunction in autosomal dominant RP due to Class B1 RHO mutations, which include T-17M [10]. Loss of immunoreactivity for cytoplasmic proteins
in cones may correspond to the time when neighboring rods
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tions need to be extended to additional RP retinas, but would
appear to be inconsistent with the equivalent-light hypothesis
for rod cell degeneration in RP [38].
Although this study documented loss of immunoreactivity for cytoplasmic proteins and did not measure mRNA levels, the results are consistent with down regulated expression
of these proteins. If this is the case, the results suggest that
protein renewal has been markedly reduced in cones in response to mutant rod cell dysfunction or death. Decreased protein renewal is also consistent with the severe OS shortening
observed in the surviving cones. Other studies have suggested
that normal rods have a trophic influence on neighboring cones
[16-18], but the putative survival agent has not yet been identified. As noted previously [20], IRBP immunoreactivity was
decreased in all four RP examined in the present study, suggesting that loss of this rod-derived protein might lead to cone
OS shortening and final cone cell death.
Results from the present study suggest that loss of an unknown rod factor leads to decreased protein synthesis and,
finally, to degeneration of the neighboring cones. However,
we found loss of cytoplasmic protein reactivity in otherwise
normal appearing cones surrounded by mutant but also normal appearing rods with shortened OS in the T-17-M RHO
mutant retina. This suggests that a putative down regulation
of cone protein expression is a response to loss of relatively
few rod cells, not an end result of massive rod cell death. If
this is true, initial rod cell death may affect neighboring cones
in a dominant manner, rather than by simply reducing the putative trophic factor derived from rods. This could be secondary to the release of a toxic factor or from reduced input by
rods into the neural network that interconnects rods and cones
in the outer plexiform layer. It is important to obtain further
information on this mechanism, as cones are critical cells essential for daytime vision in the RP patients.
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